Background: Somatic illness and its consequences evoke strong emotions of various kinds. They may affect the course of illness and the treatment results through their physiological components. The purpose of the study was to explore emotional reactions to different kinds of illnesses and changes of these emotions over time. Methods: Subjects were 259 medical patients suffering from: primary hypertension, myocardial infarction and cancer of the lungs or pharynx. The study was longitudinal and consisted of three phases. The first was performed immediately after the patient was diagnosed, the second was done 5 weeks later and the third about half a year after the onset of illness. The patients’ emotional state was evaluated with the Gottschalk-Gleser Content Analysis Scales: the Anxiety and the Hope Scales. Results: Significant effects of the kind of illness and of its interaction with the phase of the study were found. In the hypertension group, both anxiety and hope were slightly elevated immediately after diagnosis, then slightly lowered. The myocardial infarction group exhibited a low level of these emotions in the first phase, an increase in the second and then a little decrease. Cancer patients manifested high anxiety and relatively low hope in the initial phase, then a decrease in anxiety and an increase in hope. Conclusions: Both anxiety and hope accompany the illness in its consecutive phases, reflecting properties of illness as a source of psychological stress and the coping process.
© 1999 S. Karger AG, Basel
Number of Print Pages : 9
Number of Figures : 5, Number of Tables : 4, Number of References : 40
Psychotherapy and Psychosomatics
Founded 1953 as ‘Acta Psychotherapeutica et Psychosomatica’ by E.A.D.E. Carp and B. Stokvis, continued by Th. Spoerri (1964–1974) and P.E. Sifneos (1974–1991)
Vol. 68, No. 6, Year 1999 (Cover Date: November-December 1999)
Journal Editor: G.A. Fava, Bologna
ISSN: 0033–3190 (print), 1423–0348 (Online)
For additional information: http://www.karger.com/journals/pps
Article / Publication Details
Published online: 11/3/1999
Issue release date: November–December 1999
Number of Print Pages: 9
Number of Figures: 5
Number of Tables: 4
ISSN: 0033-3190 (Print)
eISSN: 1423-0348 (Online)
For additional information: http://www.karger.com/PPS
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.